Human Genome Sciences - Ownership and Business Overview

Life ScienceCompany

Human Genome Sciences Ownership

Who owns Human Genome Sciences?

Human Genome Sciences is owned by GSK. It was acquired on July 16, 2012.

Human Genome Sciences Business Overview

Where is Human Genome Sciences headquartered?

Human Genome Sciences is headquartered in Rockville, Maryland.

What sector is Human Genome Sciences in?

Human Genome Sciences is a life science company.

When was Human Genome Sciences founded?

Human Genome Sciences was founded in 1992.

Life Science M&A Summary in 2012

Out of 60 sectors in the Mergr database, life science ranked 18 in number of deals in 2012. The largest life science acquisition in 2012 was Amylin Pharmaceuticals - which was acquired by Bristol-Myers Squibb for $5.3B.

Join Mergr to view all 125 acquisitions of life science companies in 2012, including 18 acquisitions by private equity firms, and 107 by strategics.

Human Genome Sciences, Inc.

14200 Shady Grove Road,
Rockville, Maryland 20850
United States,
(301)309-8504

Human Genome Sciences (HGS) is a biopharmaceutical company with world-class R&D and manufacturing facilities and a newly created commercial team based in Rockville, MD. We have recently received approval for our first commercial product; and currently have several other products in the pipeline undergoing clinical trials.


 Subscribe to unlock this and 206,872
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 199K M&A Transactions
  • 202K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 80K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.